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Purpose: To present various forms of uveitis and/or retinal vasculitis attributed to Bartonella 
infection and review the impact of this microorganism in patients with uveitis.
Methods: Retrospective case series study. Review of clinical records of patients diagnosed 
with Bartonella henselae and Bartonella quintana intraocular inflammation from 2001 to 
2010 in the Ocular Inflammation Department of the University Eye Clinic, Ioannina, Greece. 
Presentation of epidemiological and clinical data concerning Bartonella infection was provided 
by the international literature.
Results: Eight patients with the diagnosis of Bartonella henselae and two patients with 
B. quintana intraocular inflammation were identified. Since four patients experienced bilateral 
involvement, the affected eyes totaled 14. The mean age was 36.6 years (range 12–62). Uveitic 
clinical entities that we found included intermediate uveitis in seven eyes (50%), vitritis in two 
eyes (14.2%), neuroretinitis in one eye (7.1%), focal retinochoroiditis in one eye (7.1%), branch 
retinal vein occlusion (BRVO) due to vasculitis in one eye (7.1%), disc edema with peripapillary 
serous retinal detachment in one eye (7.1%), and iridocyclitis in one eye (7.1%). Most of the 
patients (70%) did not experience systemic symptoms preceding the intraocular inflammation. 
Antimicrobial treatment was efficient in all cases with the exception of the case with neuroretinitis 
complicated by anterior ischemic optic neuropathy and tubulointerstitial nephritis.
Conclusion: Intraocular involvement caused not only by B. henselae but also by B. quintana 
is being diagnosed with increasing frequency. A high index of suspicion is needed because the 
spectrum of Bartonella intraocular inflammation is very large. In our study the most common 
clinical entity was intermediate uveitis.
Keywords: Bartonella, neuroretinitis, intermediate uveitis, retinal vascular occlusion
Introduction
The genus Bartonella includes more than 20 species, of which the members are 
small Gram-negative, fastidious, hemotropic, intracellular bacteria belonging to the 
α-2 subdivision of proteobacteria. These bacteria can cause a long-lasting intraeryth-
rocytic bacteremia in their mammalian reservoir hosts and are mainly transmitted by 
bloodsucking arthropod vectors.1 Several Bartonella species have been identified to 
cause human diseases. In this article we will focus on Bartonella henselae, Bartonella 
quintana and their ocular manifestations, mainly the intraocular ones (uveitis and/
or retinal vasculitis), with regard to our cases and data provided by the international 
literature. B. henselae has been most commonly implicated in intraocular inflamma-
tion, especially recently, and there are reports concerning various forms of intraocular 
inflammation (Table 1).Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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Bartonella henselae
The major host reservoir for B. henselae is cats.2 Many 
seroepidemiological studies have been published showing 
the worldwide distribution of B. henselae infection in cats. 
The antibody prevalence in cats varies from between 
5%–10% up to 70%–80% depending on the geographical 
area tested and the domestic or stray cat status.3–9 B. henselae 
causes intraerythrocytic bacteremia in cats for several weeks, 
but usually cats are asymptomatic. Transmission between 
cats depends on the arthropod vector Ctenocephalides felis, 
or the cat flea.10 B. henselae can multiply within the digestive 
system of the cat flea and survives several days in the flea 
feces. The main source of infection for cats and also humans 
seems to be the inoculation of flea feces by contaminated cat 
claws with a cat scratch.1 Transmission to humans can also 
happen with cat biting or cat saliva through an open wound. 
The cat flea bite is probably another way of transmission 
to humans as well. Other possible vectors for B. henselae 
infection are ticks and biting flies.1 Dogs can be infected with 
B. henselae as well, but the role of dogs as reservoir hosts 
is less clear than cats.11
B. henselae causes a variety of manifestations in humans 
and the response depends on their immune status. In immu-
nocompetent individuals the response is granulomatous and 
suppurative. In immunocompromised patients the response 
is mainly vasoproliferative.12
In immunocompetent individuals there is a wide spectrum 
of clinical manifestations:
1.  Typical cat scratch disease is the most common mani-
festation. After a cat scratch at the site of the inoculation 
a papule or pustule is formed and there is a regional 
lymphadenopathy with or without fever. The affected 
nodes may become suppurative.13
2.  Fever of unknown origin (FUO). Prolonged fever .2 
weeks without any symptoms or signs of an obvious 
clinical disease.14
3.  Ocular manifestations: Parinaud oculoglandular syn-
drome consists of follicular conjunctivitis and regional 
lymphadenopathy. Posterior segment manifestations 
include neuroretinitis, focal retinitis, choroiditis or 
retinochoroiditis, multifocal retinitis, choroiditis or 
retinochoroiditis, intermediate uveitis, branch retinal 
artery and vein occlusions, vasculitis and angiomatous 
vasoproliferative lesions that are rare and mostly seen in 
immunocompromised patients.15,16
4.  Other clinical manifestations 
  Hepatosplenic manifestations: Granulomatous and sup-
purative disease of the liver and spleen with systemic 
symptoms as prolonged fever and with or without 
abdominal pain, hepatomegaly or splenomegaly.17
  Cardiovascular manifestations: Endocarditis is the most 
common cardiac complication. Bartonella species are 
responsible for about 3% of cases of endocarditis.18,19 
Myocarditis is a rare complication.
  Neurologic manifestations: They are rare and include 
encephalopathy, seizures, status epilepticus, meningitis, 
meningoencephalitis, peripheral facial nerve paralysis, 
coma, transverse myelitis and acute hemiplegia.20–22
  Hematologic manifestations: They are rare and include 
hemolytic anemia and thrombocytopenic purpura.
  Renal manifestations: Glomerulonephritis is a rare 
complication.23
Table 1 Bartonella species found to cause systemic and ocular manifestations
Classification Human diseases
Bartonella  
species
reservoir  
host
Accidental  
host
Vector systemic  
manifestations
Ocular manifestations
B. henselae Cats Human, dog Cat flea, ticks?,  
biting flies?
CsD, FUO, hepatosplenic  
abscesses, neurologic  
manifestations, endocarditis,  
myocarditis, glomerulonephritis,  
pseudomalignancy,  
osteomyelitis, BA, BP
POGs, Neuroretinitis, retinitis, 
choroiditis, intermediate uveitis, vascular 
occlusions, vasculitis, iridocyclitis, 
angiomatous lesions
B. quintana Human Cat, dog,  
monkey
Human body louse,  
cat flea, ticks?
Trench fever, endocarditis, BA,  
lymphadenopathy
Neuroretinitis, POGs, retinitis, vasculitis,  
anterior, intermediate and posterior 
uveitis
B. grahamii rodent Human Rodent flea Neuroretinitis, retinitis, vasculitis, papillitis,   
anterior and posterior uveitis, retinal  
vascular occlusion
B. elizabethae rodent Human, dog Rodent flea endocarditis Neuroretinitis
Abbreviations: CsD, cat scratch disease; FUO, fever of unknown origin; BA, bacillary angiomatosis; BP, bacillary peliosis; POGs, Parinaud’s oculoglandular syndrome.Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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  Orthopedic manifestations: Osteomyelitis and arthritis 
are rare complications.24,25
  Pseudomalignancy: Simulating lymphoma, mimicking 
breast tumor, simulating a malignant process of the chest 
wall, simulating rhabdomyosarcoma, mimicking parotid 
malignancy.26–30
In immunocompromised patients the response is mainly 
vasoproliferative:
  Bacillary angiomatosis: Refers to skin proliferative vas-
cular lesions that may resemble Kaposi’s sarcoma. Red 
or brown papules, angiomatous nodules, pedunculated 
lesions, or deep subcutaneous masses.31,32
  Bacillary peliosis: Refers to proliferative vascular lesions 
in liver and spleen.33
Bartonella quintana
The major reservoir hosts for B. quintana are humans. 
The disease is transmitted among humans by the human 
body louse, Pediculus humanus corporis. The human body 
louse lives on the body and in the clothes or bedding of 
its human host.34 Seroepidemiological studies in home-
less people living in poor conditions show an antibody 
prevalence that varies from 2% up to 57%.35–38 B. quintana 
can multiply within the digestive system of the louse and 
survives in louse feces. Transmission to humans occurs via 
inoculation of infectious louse feces through altered skin.1 
Lice cause local skin irritation because they inject biological 
proteins with their bites resulting in itching, scratching and 
inoculation of B. quintana. Transmission of B. quintana to 
a human has also been demonstrated to happen with a cat 
bite.39 B. quintana has been found present in dogs, cats,40 
cat fleas and also monkeys.41 Ticks could also be a possible 
vector.11
Clinical manifestations
1.  Trench fever. During World War I more than 1 million 
people were infected. After World War II the incidence of 
the disease was very low but recently the incidence increased 
in people living in poor conditions and occasionally infested 
by body lice such as the homeless, drug addicts and alco-
holics. Trench fever is characterized by recurrent attacks of 
5-day cycling fever, headaches and dizziness.34,42
2.  Chronic bacteremia.
3.  Endocarditis.18
4.  Bacillary angiomatosis, especially in immunocompro-
mised individuals.34,42
5.  Lymphadenopathy.
6.  Ocular manifestations: neuroretinitis, anterior, intermedi-
ate and posterior uveitis.43
Ocular manifestations  
of Bartonella infection
The most common ocular manifestation of B. henselae infec-
tion is Parinaud’s oculoglandular syndrome (POGS). The 
syndrome was named after Henri Parinaud who described it 
for the first time in 1889.44 Nearly 5% of symptomatic patients 
with cat scratch disease have POGS.13 Patients present with 
fever, granulomatous conjunctivitis and regional lymphade-
nopathy affecting the preauricular, submandibular or cervical 
lymph nodes. Typical symptoms include unilateral eye red-
ness, foreign body sensation and epiphora.15 Transmission 
is considered to happen through inoculation of contaminated 
flea feces from the hands to the eye, because direct cat 
scratches to the conjunctiva are unusual.16 B. quintana has 
also been found in a case report to be the causative organism 
in a patient with POGS.45
Neuroretinitis affects 1% to 2% of patients with 
B. henselae infection.13,46 There is optic nerve head swelling 
with complete or partial macular star formation. Among 
patients with neuroretinitis the most common cause is B. 
henselae and approximately two-thirds have positive sero-
logic   testing.47 Patients present with unilateral, painless, 
sudden visual loss and systemic symptoms can also be 
present.48 Bilateral neuroretinitis is rare and the simultaneous 
presence of neuroretinitis and POGS is also uncommon.49,50 
Some patients with neuroretinitis also present with multifocal 
  retinochoroiditis.48 Optic disc edema associated with peri-
papillary serous retinal detachment can be an early sign of 
systemic B. henselae infection.51 Usually after 2 to 4 weeks 
a macular star formation follows, but in some patients this 
may not happen. The macular exudates may take months 
to resolve. After the resolution of neuroretinitis, a mild 
optic neuropathy may persist. Some patients may have disc 
pallor, decreased contrast sensitivity, abnormal visually 
evoked potentials, dyschromatopsia and persistent affer-
ent pupillary defects.52 Other causes of neuroretinitis that 
should be included in the differential diagnosis are syphilis, 
tuberculosis, Lyme disease, toxoplasmosis, toxocariasis, lep-
tospirosis, sarcoidosis, malignant hypertension, diabetes and 
increased intracranial pressure.15,16 B. quintana, B. grahamii 
and B. elizabethae have also been found to be causes of 
neuroretinitis.53–55
Other posterior segment manifestations of patients with 
B. henselae infection include focal or multifocal retinitis, Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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choroiditis or retinochoroiditis with or without the   presence 
of neuroretinitis or disc edema. Branch retinal artery and 
vein occlusions and serous retinal detachment, macular 
hole, panuveitis with diffuse choroidal thickening simulat-
ing Vogt–Koyanagi–Harada syndrome, vitritis, vasculitis 
and papillitis have been noted by several authors.48,56–62 
B. quintana and B. grahamii have been found to be causes 
of retinitis, vasculitis and papillitis.43 B. grahamii has also 
been found to cause retinal vascular occlusion.63
In immunocompromised patients with B. henselae 
infection, retinal bacillary angiomatosis and subretinal 
vascular mass have been observed.64 Angiomatous lesions 
have also been observed in immunocompetent patients.56 
Anterior and intermediate uveitis can be seen in B. henselae 
and B. quintana infection.43,65 B. grahamii also can cause 
anterior uveitis.43
Patients and methods
In a series of consecutive patients with intraocular inflam-
mation (ie, uveitis, retinal vasculitis) examined and treated 
during the recent 10 years in the Ocular Inflammation Depart-
ment of the University Eye Clinic of Ioannina (Greece), the 
implication of both B. henselae and B. quintana was also 
explored. In all patients, a meticulous diagnostic approach to 
inflammation was carried out, concerning infectious diseases 
(including brucellosis, tuberculosis, syphilis, toxoplasmosis, 
toxocariasis, leptospirosis, Lyme disease, bartonellosis and 
infection due to herpes simplex virus, herpes zoster virus, 
cytomegalovirus, Epstein–Barr virus and human immuno-
deficiency virus I+II), sarcoidosis and other autoimmune 
diseases, and specific idiopathic uveitic syndromes as well.
The diagnosis of a Bartonella infection was based on:
1.  History of traumatic cat exposure (scratching and/or bit-
ing) or even licking through an open wound.
2.  Serologic testing for B. henselae and B. quintana 
using indirect fluorescence assay (IFA). The laboratory 
examination of the sera was carried out at the Pasteur 
Institute of Athens. Titers , 1:32 were considered 
negative, titers of $1:64 were considered positive 
(high diagnostic value), titers = 1:32 were considered 
uncertain (moderate diagnostic value).66 The sensitiv-
ity and specificity of the test depend on the serological 
cutoff value chosen. For a cutoff value = 1:32 (sensitiv-
ity = 0.80   specificity = 0.85). For a cutoff value of $1:64 
  (sensitivity = 0.70;   specificity = 0.95). The best com-
promise between specificity and sensitivity is obtained 
with a cutoff value between 1:32 and 1:64.66 In our cases 
with positive history of cat attack and absence of another 
diagnosis, the cutoff value 1:32 was considered as posi-
tive in order to avoid an underdiagnosis of Bartonella 
infection.
3.  Presence of an intraocular inflammation not attributed to 
other causes.
4.  Previous illness (preceding the intraocular inflammation).
5.  Presence of human body lice.
Patients with a diagnosis of Bartonella intraocular 
inflammation were treated with the appropriate antibiotics 
(the main antibiotics used were doxycycline, rifampicin and 
azithromycin)16 and were followed-up for the evaluation of 
the final outcome of the ocular disease and for any eventual 
systemic complication due to Bartonellosis.
Our results were compared to those of other authors 
with regard to the intraocular findings (anterior uveitis, 
intermediate uveitis, vitritis, neuroretinitis, choroiditis, reti-
nal vasculitis and vascular occlusion), diagnostic approach, 
appropriate treatment and outcome. A thorough analysis 
of the data provided by the international literature regard-
ing Bartonella ocular infections, with a particular focus on 
intraocular involvement, was carried out in order to obtain 
a profile of the manifestations of intraocular infection due to 
Bartonella species, and avoid underdiagnosis.
Results
Intraocular inflammation was attributed to Bartonella (either 
henselae or quintana) in 10 patients. This number constitutes 
0.33% of the cases with uveitis examined in our department 
during the same period (last decade). Table 2 presents the 
profile of patients with intraocular inflammation considered 
to be of Bartonella origin. Ages ranged from 12 to 62 years 
(mean age 36.6). In eight patients the causative organism was 
Β. henselae. In seven of them there was a history of traumatic 
cat exposure (scratching and/or biting) and in one of them 
there was a history of cat licking through an open wound. 
In two patients the causative organism was B. quintana. 
In these two patients, one had pubic lice and the other was a 
worker in the fur industry, suggesting a possible tick or flea 
bite. Neither patient had a history of traumatic cat exposure.
In our series of ten patients, six patients were male and 
four female. Four patients had bilateral involvement and 
there were 14 affected eyes. In terms of eye involvement 
the clinical findings were: intermediate uveitis in seven 
eyes (50%); vitritis in two eyes (14.2%); neuroretinitis in 
one eye (7.1%); focal retinochoroiditis in one eye (7.1%); 
branch retinal vein occlusion (BRVO) due to vasculitis in 
one eye (7.1%); disc edema with peripapillary serous retinal 
detachment in one eye (7.1%); and recurrent iridocyclitis Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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Table 2 Profile of patients with intraocular inflammation considered of Bartonella origin
Patients  
(gender, age)
Mode of  
transmission
Preceding clinical  
manifestations
Intraocular  
manifestations
Microorganism IgG titers   
(IFA)
1. M 60 scratching Neuroretinitis B. henselae 1:32
2. F 12 scratching (f 1 m before uveitis 
signs and 2 w after scratching)
Focal retinochoroiditis B. henselae 1:32
3. M 31 scratching and biting Vitritisb B. henselae 1:64
4. M 36 scratching BrVO (+ periphlebitis) B. henselae 1:32
5. M 30 scratching (skin pustule at scratching  
site 6 w before uveitis onset)
intermediate uveitis B. henselae 1:64
6. F 28 scratching intermediate uveitisc B. henselae 1:32
7. M 41 scratching (POGs, malaise 3 w before  
uveitis signs)
intermediate uveitisc B. henselae 1:32
8. F 27 Pubic lice intermediate uveitisc B. quintana 1:128
9. F 39 Worker in furs  
elaboration industrya
recurrent iridocyclitis B. quintana 1:64
10. M 62 Licking Optic disc edema with 
peripapillary srD
B. henselae 1:128
Notes: aPossible tick or flea bite; bBilateral vitritis; cBilateral involvement along with peripheral vasculitis. 
Abbreviations: f, fever; m, month; w, weeks; POGs, Parinaud’s oculoglandular syndrome; BrVO, branch retinal vein occlusion; srD, serous retinal detachment.
in one eye (7.1%). The most common uveitic entity in our 
series of cases was intermediate uveitis. Since all patients 
with intermediate uveitis were young adults (27–41 years), 
neurological examination and MRI of the brain were carried 
out to rule out a multiple sclerosis background. The results 
were negative for multiple sclerosis.
The great majority of the cases (70%) did not experience 
a systemic or another ocular illness preceding the intraocular 
inflammatory manifestations (Table 2). Antimicrobial treat-
ment was efficient in all cases with the exception of the case 
with neuroretinitis complicated by anterior ischemic optic 
neuropathy and tubulointerstitial nephritis (case 1). The main 
antibiotics administered in our cases were rifampicin, doxy-
cycline and azithromycin. Ciprofloxacin and ceftriaxone were 
also used in cases with treatment failure, allergy and early 
side-effects. Table 3 presents the visual acuities before and 
after treatment, the antibiotics used to eradicate the microor-
ganism, and the complications seen during follow-up.
Case reports
Case 1
Sixty-year-old male with a history of cat scratching and without 
any systemic manifestations. In his left eye, neuroretinitis was 
observed 1 month after cat scratching (Figure 1A). The IgG 
titer for B. henselae was 1:32. The visual acuity in the affected 
left eye was 0.05 before treatment. The right eye was not 
affected. He was treated with ciprofloxacin 750 mg daily 
and doxycycline 100 mg 12 hourly for 4 weeks, followed by 
ceftriaxone 1 g 12-hourly for 1 week. The visual acuity after 
treatment was 0.025. This patient developed anterior ischemic 
optic neuropathy (AION) 3 weeks after the onset of disease 
(neuroretinitis) with characteristic visual field defect and had 
a poor outcome in spite of treatment (Figure 1B); in addition, 
tubulointerstitial nephritis occurred 3 months after the diagnosis 
of neuroretinitis suggesting possible tubulointerstitial nephritis-
uveitis (TINU) syndrome.67 This patient had abnormal renal 
function with elevated serum creatinine. The urine analysis 
was abnormal showing low grade proteinuria, hematuria and 
increased beta-2 microglobulin. Also mild anemia (hemoglobin 
12 g/dL) and an abnormal elevated erythrocyte sedimenta-
tion rate (ESR 96 mm/hour) were noted. A renal biopsy was 
not performed and the patient was treated successfully with 
systemic corticosteroids for the renal disease. The final visual 
acuity of his left eye was counting fingers at 30 cm.
Case 2
Twelve-year-old girl with a history of cat scratch and fever 
2 weeks later. Six weeks after the cat scratch, a focal retin-
ochoroiditis was observed in her right eye. The IgG titer for 
B. henselae was 1:32. The visual acuity in the affected right 
eye was 0.5 before treatment. The left eye was not affected. 
She was treated with rifampicin 600 mg daily and doxycy-
cline 100 mg 12 hourly for 4 weeks with complete resolution 
of the uveitis. The visual acuity after treatment in the affected 
right eye was 1.0. During the follow-up, a chorioretinal 
extrafoveal scar was observed in the location of the focal 
retinochoroiditis, which did not affect visual acuity.
Case 3
Thirty-one-year-old male with a history of cat scratching and 
biting and without any systemic symptoms. Bilateral vitritis Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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Figure 1 Patient 1 (Tables 2 and 3) with neuroretinitis: optic disc edema and macular star (A) and AiON (B) with characteristic visual fields defect and positive serology for 
Bartonella henselae and history of cat scratch.
Abbreviation: AiON, anterior ischemic optic neuropathy.
A
Table 3 Treatment and outcome in ten cases with intraocular inflammation due to B. henselae and B. Quintana
VA  
(before treatment)
VA  
(after treatment)
Treatment Follow-up  
(years)
Complications
RE LE RE LE
1.0 0.05 1.0 0.025 Ciprofloxacin 750 mg (daily)  
Doxycycline 100 mg (12-hourly)  
4 weeks  
Followed by (iV)  
Ceftriaxone 1 g (12-hourly)  
1 week
6 AiON (arteritic) re,   
TiNU  
Final VA re:  
CF/30 cm
0.5 1.0 1.0 1.0 rifampicin 600 mg (daily)  
Doxycycline 100 mg  
(12-hourly) 4 weeks
7 Chorioretinal scar  
re (extrafoveal)
0.9 0.8 1.0 1.0 rifampicin 600 mg (daily)  
Azithromycin 500 mg (daily) 
4 weeks
5 Myocarditis (1 year  
after the onset of  
the ocular disease)
1.0 0.8 1.0 1.0 rifampicin 600 mg (daily) 
Azithromycin 500 mg  
(daily) 4 weeks
2.5
1.0 0.5 1.0 1.0 Ciprofloxacin 500 mg (12-hourly) 
4 weeks
7 erM of the macula  
(VA Le: 1.0 → 0.9)
0.6 0.8 1.0 1.0 rifampicin 600 mg (daily)  
Doxycycline 100 mg (12-hourly)  
4 weeks
1
0.7 0.8 1.0 1.0 rifampicin 600 mg (daily)  
Doxycycline 100 mg (12-hourly)  
4 weeks
2 erM of the macula  
(VA re: 1.0 → 0.8)
0.9 0.9 1.0 1.0 rifampicin 600 mg (daily)  
Doxycycline 100 mg (12-hourly)  
4 weeks
2
1.0 0.8 1.0 1.0 Doxycycline 100 mg (12-hourly)  
Azithromycin 500 mg (daily)  
4 weeks
3 Cataract formation  
(VA Le: 1.0 → 0.9)
0.7 cataract 0.4 0.7 cataract 0.9 rifampicin 600 mg (daily)  
Doxycycline 100 mg (12-hourly)  
4 weeks
1
Note: The visual acuities in bold italics concern the affected eyes. 
Abbreviations: r, rifampicin; D, doxycycline; A, azithromycin; iV, intravenous; AiON, anterior ischemic optic neuropathy; TiNU, tubular interstitial nephritis and uveitis; 
erM, epiretinal membrane; VA, visual acuity, re, right eye; Le, left eye.Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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was observed 6 weeks after cat scratching. The IgG titer for 
B. henselae was 1:64. The visual acuities before treatment 
in the affected eyes were 0.9 in the right eye and 0.8 in 
the left eye. He was treated with rifampicin 600 mg daily 
and azithromycin 500 mg daily for 4 weeks with complete 
resolution of the uveitis. The visual acuities after treatment 
were 1.0 in both eyes. One year after the onset of uveitis, the 
patient developed myocarditis,68 not associated with another 
preexisting heart disease with regard to cardiological investi-
gation. The medical history of the patient was also negative 
for other infectious diseases causing myocarditis.
Case 4
Thirty-six-year-old male with BRVO in his left eye and recur-
rence of macular edema after the treatment with laser photoco-
agulation and intravitreal bevacizumab (Figure 2A, B, C, D). 
A more meticulous medical history revealed a recent episode 
of cat scratching 4 weeks before the onset of BRVO without 
any systemic symptoms. In addition, pedantic analysis of 
fluorescein angiography features took into account along with 
the BRVO the presence of retinal phlebitis (Figure 2C and D). 
Therefore, a diagnostic approach for retinal vasculitis and labo-
ratory examination of the serum for B. henselae and quintana 
was carried out. The IgG titer for B. henselae was 1:32. Visual 
acuity before treatment in the affected left eye was 0.8. He was 
treated with rifampicin 600 mg daily and azithromycin 500 mg 
daily for 4 weeks, resulting in an improvement of visual acuity 
and regression of macular edema (Figure 2E, F, G, H). The 
visual acuity after treatment in the affected left eye was 1.0. No 
recurrence either of macular edema or of retinal vasculitis was 
observed during a long follow-up period (2 1/2 years).
Case 5
Thirty-year-old male with a history of cat scratching. At the 
site of inoculation a pustule was formed and after 6 weeks 
intermediate uveitis was observed in his left eye (Figure 3A). 
The IgG titer for B. henselae was 1:64. The visual acuity before 
treatment in the affected left eye was 0.5. The right eye was not 
affected. He was treated with ciprofloxacin 500 mg 12-hourly 
for 4 weeks with complete resolution of the intermediate 
uveitis (Figure 3B). The visual acuity after treatment in the 
affected left eye was 1.0. A late complication was noticed in 
the left eye during follow-up; an epiretinal membrane of the 
macula was observed and the final visual acuity was 0.9.
Case 6
Twenty-eight-year-old female with a history of cat scratching 
and without any systemic symptoms. Bilateral intermediate 
uveitis along with peripheral vasculitis was observed 5 weeks 
after cat scratching. The IgG titer for B. henselae was 1:32. 
The visual acuities in the affected eyes before treatment were 
0.6 in the right eye and 0.8 in the left eye. She was treated with 
rifampicin 600 mg daily and doxycycline 100 mg 12-hourly 
for 4 weeks with complete resolution of the bilateral uveitis. 
The visual acuities after treatment in the affected eyes were 
1.0 in both of them.
Case 7
Forty-one-year-old male with a history of cat scratching 
followed after 2 weeks by malaise along with POGS. Five 
weeks after cat scratching, bilateral intermediate uveitis along 
with peripheral vasculitis was observed. The IgG titer for 
B. henselae was 1:32. The visual acuities before treatment 
in the affected eyes were 0.7 in the right eye and 0.8 in the 
left eye. He was treated with rifampicin 600 mg daily and 
doxycycline 100 mg 12-hourly for 4 weeks with complete 
resolution of the bilateral intermediate uveitis. The visual 
acuities after treatment in the affected eyes were 1.0 in both 
of them. A late complication was noticed in the right eye 
during follow-up; an epiretinal membrane of the macula was 
observed and the final visual acuity was 0.8.
Case 8
Twenty-seven-year-old female with a history of pubic lice 
and without any systemic symptoms. She did not have a his-
tory of traumatic cat exposure. Bilateral intermediate uveitis 
along with peripheral vasculitis was observed (Figure 4A, B, 
C, D). The IgG titer for B. quintana was 1:128. The visual 
acuities before treatment in the affected eyes were 0.9 in the 
right eye and 0.9 in the left eye. She was treated with rifam-
picin 600 mg daily and doxycycline 100 mg 12-hourly for   
4 weeks with complete resolution of the bilateral intermedi-
ate uveitis. The visual acuities after treatment in the affected 
eyes were 1.0 in both of them.
Case 9
Thirty-nine-year-old female with a history of recurrent unilat-
eral iridocyclitis. She had three recurrences of inflammation 
in her left eye in a period of 1 year before the examination in 
our department. The iridocyclitis was a nongranulomatous 
one with posterior synechiae (Figure 5). She did not have any 
systemic symptoms. The IgG titer for B. quintana was 1:64. 
She was a worker in the furs elaboration industry, suggest-
ing a possible tick or flea bite. She didn’t have a history of 
traumatic cat exposure. The visual acuity before treatment in 
the affected left eye was 0.8. The right eye was not affected. Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
Dovepress 
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Figure 2 Patient 4 (Tables 2 and 3). A, B, C, D: BrVO along with cystoid macular edema (CMe) in OCT and signs of vasculitis (FA arrows) treated previously with laser and 
intravitreal bevacizumab (positive serology for Bartonella henselae and history of cat scratch). E, F, G, H: After 4 weeks’ treatment with azithromycin and rifampicin, there is 
a significant improvement of fundus findings along with FA findings and total regression of CME (OCT). 
Abbreviations: BrVO, branch retinal vein occlusion; FA, fluorescein angiography; OCT, optical coherence tomography; CME, cystoid macular edema.Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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Figure 3 Patient 5 (Tables 2 and 3) with positive serology for Bartonella henselae and history of cat scratch, presenting with unilateral intermediate uveitis. A) before 
treatment and B) after 4 weeks treatment with ciprofloxacin: regression of uveitis (the absence of snowballs is notable).
Figure 4 Patient with bilateral intermediate uveitis and peripheral vasculitis (increased igG titers against B. quintana; patient 8 in Tables 2 and 3). (A) and (B) right 
eye with snowballs masking the vessels with mild vasculitis in fluorescein angiography (FA), (C) and (D) the vasculitis is more prominent in left eye; in FA segmental 
periphlebitis is present.Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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She was treated with doxycycline 100 mg 12-hourly and 
azithromycin 500 mg daily for 4 weeks with complete reso-
lution of the uveitis. The visual acuity after treatment in the 
affected left eye was 1.0. There were no recurrences during 
the 3-year follow-up period. Because of cataract formation 
in the left eye during follow-up, the final visual acuity in the 
left eye was 0.9.
Case 10
Sixty-two-year-old male with a history of cat licking through 
an open wound and without any systemic symptoms. Optic 
disc edema associated with peripapillary serous retinal 
detachment was observed in his left eye 5 weeks after cat 
licking. The IgG titer for B. henselae was 1:128. The visual 
acuity before treatment in the affected left eye was 0.4. The 
right eye was not affected. He was treated with rifampicin 
600 mg daily and doxycycline 100 mg 12-hourly for 4 weeks 
with complete resolution of the uveitis. Visual acuity after 
treatment in the affected left eye was 0.9.
Discussion
Our knowledge about Bartonella species has increased in 
the last few years and there are many reports about ocular 
manifestations of Bartonella infection. B. henselae has 
been found to cause POGS, neuroretinitis, retinochoroidi-
tis, retinal vascular occlusions, vasculitis, vitritis, anterior 
uveitis, intermediate uveitis, posterior uveitis, papillitis 
and other ocular complications.15,16,43,46,48,56,59 B. quintana 
has been found to cause POGS, neuroretinitis, retinitis, 
vasculitis, papillitis, anterior, intermediate and posterior 
uveitis.43,45,53 B.   grahamii has been found to cause retinitis, 
vasculitis, papillitis,   retinal vascular occlusion, anterior and 
posterior uveitis.43,63 B.   elizabethae has been found to cause 
  neuroretinitis.55 It is important in patients with these ocular 
manifestations to know if there is a history of traumatic 
cat exposure, the presence of systemic symptoms such as 
fever, headache, lymphadenopathy or the presence of body 
lice. Since uveitis seems to be an emerging clinical form of 
  Bartonella infection, patients with uveitis of unknown etiol-
ogy should be tested for Bartonella species.43
The most common uveitic entity in our series of cases 
was intermediate uveitis. In the patients with intermediate 
uveitis snowballs and/or snowbanks were noted and three of 
them had bilateral involvement with peripheral vasculitis. 
There was also a patient with bilateral vitritis. According 
to the Standardization of Uveitis Nomenclature (SUN) 
working group69 vitritis is included in the clinical entity of 
intermediate uveitis. This means that the total number of 
affected eyes with intermediate uveitis was nine (64.2%). 
To our knowledge this is the first report of a series of cases 
of ocular bartonellosis in which intermediate uveitis is the 
prominent clinical entity. In other published series of cases, 
neuroretinitis associated with macular star57 and isolated foci 
of retinitis or choroiditis70 were the most common intraocular 
findings in cat scratch disease (CSD). In a recent study from 
two Brazilian uveitis reference centers the most common 
findings of CSD were retinal infiltrates and angiomatous 
lesions.56 In another study that explored the implication of B. 
henselae, B. quintana and B. grahamii as causes of uveitis, 
the most common clinical entity found was posterior uveitis.43 
The spectrum of intraocular manifestations of Bartonella 
infection is very large and this must be kept in mind.
In our series of cases there was a patient who, 1 year 
after the onset of the ocular disease (bilateral vitritis), had 
the complication of myocarditis. There is a study that reports 
chronic active myocarditis after B. henselae infection. The 
mechanism is believed to be that of secondary lymphocyte 
mediated immune response.71 This could also be the case in 
our patient.
The case of our patient who presented with neuroretini-
tis was complicated after 3 months with tubulointerstitial 
nephritis (possible TINU syndrome). The etiology of TINU 
syndrome remains unclear. TINU is thought in be an immune-
mediated process and there are associations with some infec-
tious agents, several drugs and toxins. However it can be 
idiopathic.67 In our case, the possible TINU syndrome could 
be associated with B. henselae or the antibiotic treatment used 
to eradicate the microorganism. To our knowledge this is the 
first reported case of a possible association of Bartonella 
Figure 5 recurrent nongranulomatous iridocyclitis with posterior synechiae in the 
left eye of a patient working in a furs elaboration industry, with positive serology for 
B. quintana (patient 9 in Tables 2 and 3).Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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infection and TINU. The same patient also developed AION 
before the onset of interstitial nephritis. Those sequential 
events following neuroretinitis could suggest an immune 
associated mechanism triggered by Bartonella infection.
There are recent reports of anterior uveitis caused by 
Bartonella species.43 Iridocyclitis due to Bartonella infection 
may be granulomatous or nongranulomatous as well and 
recurrent iridocyclitis has been also reported.72
Bartonella species are fastidious bacteria, difficult to 
grow and requiring long incubation periods in enriched media 
for 2 to 6 weeks. Often isolation in culture is unsuccessful. 
The diagnosis of Bartonella infection is commonly made 
using serologic testing with immunofluorescence antibody 
analysis (IFA) or enzyme-linked immunosorbent assay 
(ELISA).66,73 The sensitivities and specificities of these meth-
ods vary in different reports and different cutoff values are 
used. The chosen cutoff value in the serological examination 
(IFA) in the patients of our study reflects our effort to avoid 
underdiagnosis. If serology is negative, a second sample after 
2 months may show a seroconversion. Cross-reactions have 
been reported between Bartonella species and with Coxiella 
burnetti and Chlamydia pneumoniae. Western blot analysis 
and cross-adsorption can solve this problem and increase 
the specificity of the test.34 Also polymerase chain reaction 
(PCR) analysis of tissue samples can be used for diagnosis.74 
Intraocular fluid analysis using PCR can confirm the diagno-
sis of Bartonella intraocular inflammation as well.43
In immunocompetent patients the ocular manifestations 
of Bartonella infection tend to be self-limited and have a 
benign course. However, some patients may have more 
severe ocular complications, especially those with intraocular 
  inflammation. Early antibiotic treatment seems to shorten 
the course of infection and hasten visual recovery52 and this 
was also the basis of the management of our patients with 
  Bartonella uveitis. In immunocompromised patients,the 
ocular manifestations tend to be more severe and an early 
intensive antibiotic treatment is required. A variety of 
antibiotics have been reported to have good efficacy includ-
ing rifampicin, doxycycline, azithromycin, ciprofloxacin, 
trimethoprim-sulfamethoxazole and gentamycin. The antibi-
otic treatment lasts 2–4 weeks for immunocompetent patients 
and up to 4 months for immunocompromised patients.16 
In our patients, all immunocompetent, a 4-week treatment 
protocol was performed to eradicate the infectious agent.
Pet owners should be informed about the risks that exist 
from the infestation of the pets with fleas or ticks and control 
measures should be taken to avoid such infestation. Also 
homeless people, drug addicts and alcoholics should be 
informed of the risks that exist from the presence of human 
body lice and control measures should be taken as well. In 
addition, these individuals, because of the poor living condi-
tions and lack of hygiene, may also be exposed to rodent-
borne Bartonella species. Finally, immunocompromised 
patients should be especially careful, because Bartonella 
infection can be severe or even fatal for them, and prevention 
is the best solution.
Intraocular involvement caused not only by B. henselae 
but also by B. quintana is being diagnosed with increasing 
frequency. The combination of POGS and intraocular inflam-
mation in the same patient seems to be very rare and this is 
also observed in our own cases.50 Although the possibility of 
B. henselae infection should be considered in patients with 
neuroretinitis, other forms of uveitis and retinal vasculitis 
may be present even in the absence of systemic symptoms 
of cat scratch disease, especially in cases of B. quintana 
infection, which is underestimated as a cause of intraocular 
inflammation. Serological data must be interpreted especially 
along with a positive history of exposure to cat-scratching 
or biting, and the clinical picture; a high index of suspicion 
should be retained, because some associations may remain 
underdescribed.
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